The effect of profound LH suppression in GnRH antagonist cycles on IVF/ICSI outcomes-A retrospective study of 400 cycles

被引：0
|
作者：
Ramineedi, D. [1 ]
Mantravadi, K. C. [1 ]
Gedela, D. R. [1 ]
机构：
[1] Oasis Fertil, Reprod Med, Hyderabad, India
来源：
HUMAN REPRODUCTION | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-646
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles:: a prospective randomized study
    Cédrin-Durnerin, I
    Grange-Dujardin, D
    Laffy, A
    Parneix, I
    Massin, N
    Galey, J
    Théron, L
    Wolf, JP
    Conord, C
    Clément, P
    Jayot, S
    Hugues, JN
    HUMAN REPRODUCTION, 2004, 19 (09) : 1979 - 1984
  • [2] Is ovarian response associated with adverse perinatal outcomes in GnRH antagonist IVF/ICSI cycles?
    Bardhi, Erlisa
    Blockeel, Christophe
    Cools, Wilfried
    Santos-Ribeiro, Samuel
    Racca, Annalisa
    Mackens, Shari
    Vos, Michel De
    Polyzos, Nikolaos P.
    Popovic-Todorovic, Biljana
    Brucker, Michael De
    Muzii, Ludovico
    Panici, Pierluigi Benedetti
    Tournaye, Herman
    Drakopoulos, Panagiotis
    REPRODUCTIVE BIOMEDICINE ONLINE, 2020, 41 (02) : 263 - 270
  • [3] DUAL SUPPRESSION IN GnRH ANTAGONIST CYCLES FOR PCOS PATIENTS UNDERGOING ICSI CYCLES.
    Ozmen, B.
    Cetinkaya, S. E.
    Sonmezer, M.
    Atabekoglu, C. S.
    Berker, B.
    Seval, M.
    FERTILITY AND STERILITY, 2013, 100 (03) : S354 - S354
  • [4] GnRH agonist versus GnRH antagonist in IVF/ICSI cycles with recombinant LH supplementation: DNA fragmentation and apoptosis in granulosa cells
    Lavorato, H. L.
    Oliveira, J. B. A.
    Petersen, C. G.
    Mauri, A. L.
    Massaro, F. C.
    Silva, L. F. I.
    Vagnini, L. D.
    Nicoletti, A.
    Ponte, A.
    Cavagna, M.
    Baruffi, R. L. R.
    Franco, J. G., Jr.
    HUMAN REPRODUCTION, 2011, 26 : I26 - I27
  • [5] GnRH agonist versus GnRH antagonist in IVF/ICSI cycles with recombinant LH supplementation: DNA fragmentation and apoptosis in granulosa cells
    Lavorato, Heloisa L.
    Oliveira, Joao Batista A.
    Petersen, Claudia G.
    Vagnini, Laura
    Mauri, Ana L.
    Cavagna, Mario
    Baruffi, Ricardo L. R.
    Franco, Jose G., Jr.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2012, 165 (01) : 61 - 65
  • [6] GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles:: a prospective randomized study
    Humaidan, P
    Bredkjær, HE
    Bungum, L
    Bungum, M
    Grondahl, ML
    Westergaard, L
    Andersen, CY
    HUMAN REPRODUCTION, 2005, 20 (05) : 1213 - 1220
  • [7] Does the Length of Ovarian Stimulation or Duration of GnRH Antagonist Use Affect Pregnancy Outcomes in IVF/ICSI Cycles Using a GnRH Antagonist?
    Royster, G. D., IV
    Robinson, R. D.
    Propst, A. M.
    Retzloff, M. G.
    FERTILITY AND STERILITY, 2009, 91 : S19 - S19
  • [8] GnRH agonist (buserelin) or HCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study
    Engmann, L
    Benadiva, C
    HUMAN REPRODUCTION, 2005, 20 (11) : 3258 - 3260
  • [9] Dydrogesterone versus GnRH-antagonists to supress the LH surge in IVF/ICSI cycles
    Barbakadze, L.
    Dorofeeva, U.
    Khonelidze, N.
    Karimova, G.
    HUMAN REPRODUCTION, 2024, 39 : I175 - I175
  • [10] Relationship between serum LH and IVF outcome in cycles with a GnRH antagonist (Cetrorelix).
    Bosch, E
    Valencia, I
    Crespo, J
    Simon, C
    Remohi, J
    Pellicer, A
    FERTILITY AND STERILITY, 2002, 78 (03) : S119 - S119
12345